South Africa HIV Prevention Jab Reaches 55000 People
CAPE TOWN, SOUTH AFRICA — Nearly 55,000 South Africans have received lenacapavir, the twice-yearly injectable HIV prevention drug, since its national deployment […]
CAPE TOWN, SOUTH AFRICA — Nearly 55,000 South Africans have received lenacapavir, the twice-yearly injectable HIV prevention drug, since its national deployment […]
One email a week. Verified openings, live funding calls, and one clinical insight you can use.
Check your inbox and confirm your email so the Brief can reach you. The first one lands this week.